The Venture Codex Logo

The Venture Codex

Overview

Accelerates research for facioscapulohumeral muscular dystrophy treatment.

Deals ยท 12mo

0

Stage focus

Series B

Geographic focus

United States

Sector focus

Health Care
Health Diagnostics
Medical

Investment portfolio

4rounds
NAMEDATESIZE
Armatus Bio
May 2025Led
$3 MOther Equity
Epicrispr
Mar 2025Participated
$68 MSeries B
Vita Therapeutics
Oct 2022Led
$31 MSeries B
Altay Therapeutics
Sep 2022Led
$3 MOther Equity
Armatus Bio
May 2025Led
$3 MOther Equity
Epicrispr
Mar 2025Participated
$68 MSeries B
Vita Therapeutics
Oct 2022Led
$31 MSeries B
Altay Therapeutics
Sep 2022Led
$3 MOther Equity
4
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Solve FSHD: 4 funding rounds are recorded in the selected participation categories.All available history.
Solve FSHD: 4 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Series B11
Other Equity20

Monthly Deal Activity

Solve FSHD: 4 deals are recorded across 50 months.All available history.
Solve FSHD: 4 deals are recorded across 50 months. All available history
MonthDeals
Sep '221
Oct '221
Nov '220
Dec '220
Jan '230
Feb '230
Mar '230
Apr '230
May '230
Jun '230
Jul '230
Aug '230
Sep '230
Oct '230
Nov '230
Dec '230
Jan '240
Feb '240
Mar '240
Apr '240
May '240
Jun '240
Jul '240
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '251
Apr '250
May '251
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

Solve FSHD: Health & Life Sciences is the largest displayed sector by deal count (4 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Solve FSHD: Health & Life Sciences is the largest displayed sector by deal count (4 deals). All available history
SectorDeals
Health & Life Sciences4

Deal Size Distribution

Solve FSHD: 4 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Solve FSHD: 4 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M2
$5M-$10M0
$10M-$25M0
$25M-$50M1
$50M-$100M1
$100M-$250M0
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Solve FSHD: United States has the largest recorded deal count among the displayed regions (4 deals).All available history.

Top 1 of 1 regions; European countries are grouped as Europe.

Solve FSHD: United States has the largest recorded deal count among the displayed regions (4 deals). All available history
RegionDeals
United States4
Solve FSHD: 5 co-investors are shown, with Ally Bridge Group sharing 1 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Solve FSHD: 5 co-investors are shown, with Ally Bridge Group sharing 1 recorded deals. All available history
Co-investorShared deals
Ally Bridge Group1
Cambrian Biopharma1
Cedars-Sinai Medical Center1
Riptide Ventures1
TEDCO1

Investment Strategy

Solve FSHD: Led accounts for 75% and participating for 25% of round participation.All available history.
Solve FSHD: Led accounts for 75% and participating for 25% of round participation. All available history
CategoryDeals (count)Share (%)
Led375%
Participating125%
Solve FSHD: Single-lead accounts for 67% and co-led for 33% of lead dynamics.All available history.
Solve FSHD: Single-lead accounts for 67% and co-led for 33% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead267%
Co-led133%

Team